Search All News
Columbia researchers found that a gene associated with an autoimmune form of hair loss could be activated to improve cancer immunotherapy.
Seventy-five percent of patients with an autoimmune disease that causes hair loss had significant hair regrowth after treatment with ruxolitinib.
Interdisciplinary dermatology research is helping advance understanding of conditions like alopecia areata, epidermolysis bullosa, and skin cancer.
- February 25, 2008
- April 7, 1999
- January 29, 1998